Hey, remember the time Tilray and Denise Faltischekissued the below press release (it's still on the Tilray website) - claimimg they 'iniated' a meeting with German officials - even naming the offcials?
Unfortunately, it turns out the meeting never happened and the press release was false.
Do you understand? The press release is still on the website and isn't true.
Tilray Initiates Roundtable With German Regulators to Kick-Off Draft Legislation to Legalize Adult-Use Cannabis in Germany
September 6, 2022 BERLIN, Sept. 06, 2022 (GLOBE NEWSWIRE) --
Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, today announced that the Company has initiated a policy roundtable with German regulators on adult-use cannabis legalization in Germany.
In this meeting, the German Drug Commissioner, Burkhard Blienert, presented the plan for adult-use cannabis legalization and repeated the German government’s announcement that a first draft of the bill would be presented in the coming months.
With this event, Tilray reaffirms its leading role as a trusted partner to government regulators and contributes to German legalization efforts by sharing its long-standing expertise and experience in cannabis research, product quality and safety, supply management, patient and consumer protection, and cannabis education.
Participants in the meeting included key leaders from Germany’s health and legal committees including:
Burkhard Blienert, Commissioner on Narcotic Drugs at the Federal Ministry of Health
Kristine Ltke, Member of the Bundestag (FDP), Drug Policy Spokesperson
Carlos Kasper, Member of the Bundestag (SPD), Committee on Finance
Martina Stamm-Fibich, Member of the Bundestag (SPD), Committee on Health
Denise Faltischek, Chief Strategy Officer and Head of International, Tilray Brands, Inc., said, “We are honored to have initiated this high-level exchange on one of the world's most important cannabis endeavors. As a leading global cannabis company, Tilray Brands has unmatched experience partnering with governments and regulators to help develop responsible cannabis regulations that protect the health and safety of patients and consumers, as well as, supporting significant economic growth in countries in which it operates.
We applaud the German government in leading responsible adult-use cannabis legislation in Europe and we are proud to support this effort.” Sascha Mielcarek, Managing Director, Tilray Europe, said, “As a market leader in Germany and Europe, our highest priority for a successful launch of an adult-use market in Germany is to lead with the highest quality-control standards that are consistent and reliable for consumers and patients. Established quality certifications such as European Good Manufacturing Practice (EU-GMP) already enable manufacturers industry-wide to provide patients and consumers with cannabis of the utmost quality and safety. These standards have proven themselves in our everyday medical cannabis practice and can be considered best practices for the recreational market, as they ensure consistent quality products.” Tilray Brands has a pioneering track record as a company committed to producing the highest-quality cannabis products available to consumers and patients in need around the world and was the first to successfully export medical cannabis from North America and import medical cannabis products into the EU in 2016. Tilray has made several strategic investments that are now resulting in first-mover advantages in Germany and Europe and the Company’s operational strength is reflected along the entire value chain with leading medical cannabis brands, a strong distribution network in Germany, and end-to-end EU-GMP supply chain, which includes two state-of-the-art EU-GMP production facilities in Portugal and Germany.